These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18497480)

  • 1. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of Renin-Angiotensin system inhibition on left atrial function.
    Song ZZ
    Hypertens Res; 2008 Mar; 31(3):585; author reply 585-6. PubMed ID: 18497480
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive assessment of left atrial function by strain rate imaging in patients with hypertension: a possible beneficial effect of renin-angiotensin system inhibition on left atrial function.
    Kokubu N; Yuda S; Tsuchihashi K; Hashimoto A; Nakata T; Miura T; Ura N; Nagao K; Tsuzuki M; Wakabayashi C; Shimamoto K
    Hypertens Res; 2007 Jan; 30(1):13-21. PubMed ID: 17460367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cardiac renin-angiotensin system and its role in ventricular hypertrophy associated with arterial hypertension].
    Rubattu S; Volpe M; Raman V; Lindpaintner K
    Cardiologia; 1997 Jan; 42(1):47-50. PubMed ID: 9118154
    [No Abstract]   [Full Text] [Related]  

  • 4. Left-ventricular hypertrophy and coronary artery disease.
    Pierdomenico SD
    Am J Hypertens; 2007 Oct; 20(10):1036-7. PubMed ID: 17903684
    [No Abstract]   [Full Text] [Related]  

  • 5. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
    J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Left ventricular diastolic function in subjects with arterial hypertension living in the Far North depending on the work schedule].
    Zapesochnaia IL; Avtandilov AG
    Klin Med (Mosk); 2008; 86(8):44-7. PubMed ID: 18819346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why Is Atrial Fibrillation So Frequent in Hypertensive Patients?
    Vitolo M; Lip GYH; Shantsila A
    Am J Hypertens; 2020 Dec; 33(12):1067-1070. PubMed ID: 32965491
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphism of inhibitory renin-angiotensin system as a genetic risk factor for atrial fibrillation.
    Ogimoto A; Higaki J; Miki T
    Circulation; 2004 Sep; 110(13):e329; author reply e329. PubMed ID: 15451813
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents.
    Prisant LM
    Am J Med; 2008 Aug; 121(8 Suppl):S8-15. PubMed ID: 18638617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vasoactive peptides in blood pressure control.
    Brunner HR
    J Hum Hypertens; 1993 Aug; 7(4):375-81. PubMed ID: 8410929
    [No Abstract]   [Full Text] [Related]  

  • 14. Is angiotensin II a direct mediator of left ventricular hypertrophy? Time for another look.
    Reudelhuber TL; Bernstein KE; Delafontaine P
    Hypertension; 2007 Jun; 49(6):1196-201. PubMed ID: 17452509
    [No Abstract]   [Full Text] [Related]  

  • 15. Slower heart rates for healthy hearts: time to redefine tachycardia?
    Gopinathannair R; Sullivan RM; Olshansky B
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):321-3. PubMed ID: 19808425
    [No Abstract]   [Full Text] [Related]  

  • 16. Renin-angiotensin-aldosterone system blockade in atrial fibrillation and left atrial remodelling.
    Krishnamoorthy S; Lip GY
    Int J Clin Pract; 2009 Jul; 63(7):982-5. PubMed ID: 19570114
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement of diastolic function after regression of left ventricular hypertrophy.
    Teniente-Valente R; Solorio S; Vargas-Salado E; Aguirre-Vázquez C; Hernández-González MA; Olvera-Lopez JA; Rodríguez-Mariscal L; Luna-Ruiz MA; Guillén Contreras JM; Murillo Ortiz BO
    Arch Cardiol Mex; 2008; 78(4):392-9. PubMed ID: 19205547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial deformation: the key to maintenance of sinus rhythm in patients with atrial fibrillation?
    Dokainish H; Connolly SJ
    Eur Heart J; 2008 Jun; 29(12):1483-4. PubMed ID: 18499653
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathophysiology of atrial fibrillation: importance of the renin-angiotensin system].
    Schulz R; Heusch G
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S95-8. PubMed ID: 16921449
    [No Abstract]   [Full Text] [Related]  

  • 20. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.